TrumpRx website goes live with links to discounted medicines.

TrumpRx launched as a landing page that links to pharmaceutical companies' direct-purchase platforms and offers coupons, listing negotiated discounts from companies including Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk.

TrumpRx has launched as an administration-backed website intended to make certain prescription medicines available at lower cash prices. The site does not sell drugs directly but links to drugmakers' direct-to-consumer purchase platforms and provides pharmacy coupons. Officials presented the platform in a televised Oval Office appearance, and participating manufacturers include Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk. The administration says it negotiated discounts for medicines listed on the site, but it has not disclosed the specific terms of those agreements. Key details: - The site functions as a landing page with links or coupons rather than an online pharmacy. - People with health insurance can pay cash through the platform, but those purchases may not count toward insurer deductibles or annual out-of-pocket maximums. - Participating drugmakers named on the site include Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk. - The administration negotiated listing agreements with those companies but has kept deal specifics confidential. - Some GLP-1 products for weight loss are priced on the site, with injections shown starting at $199 and an oral tablet starting dose listed at $149 per month. - The launch included officials such as Centers for Medicare and Medicaid Services administrator Mehmet Oz and Joe Gebbia from the Department of Government Efficiency task force. Summary: The platform may encourage some patients to make cash purchases and could increase access to specific medicines like certain GLP-1 products, while analysts say it is unlikely to substantially lower drug prices for most insured Americans. Undetermined at this time.